Hemostemix Inc (OTCQB:HMTXF)
| 0.171 Delayed Data As of Jan 27 |  -0.0309 / -15.30%Today’s Change | 0.08 Today|||52-Week Range 0.33 | +31.54% Year-to-Date |
Latest HMTXF News | Press Releases
No recent news for Hemostemix Inc.
Today’s Trading
| Previous close | 0.20 |
| Today’s open | 0.18 |
| Day’s range | 0.17 - 0.18 |
| Volume | 2,000 |
| Average volume (3 months) | 23,657 |
| Market cap | $13.0M |
Data as of 01/27/2023
Growth & Valuation
| Earnings growth (last year) | +51.39% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | -- |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NDRAENDRA Life Sciences ... | -0.04 | -0.99% |
| CANFCan Fite Biopharma L... | +0.02 | +0.49% |
| APVOAptevo Therapeutics ... | +0.01 | +0.42% |
| ONVOOrganovo Holdings In... | 0.00 | 0.00% |
Data as of 3:59pm ET, 01/27/2023
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$5.0M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Calgary, Alberta |
Forecasts
Chart unavailable
